SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-020626
Filing Date
2022-08-03
Accepted
2022-08-03 16:21:07
Documents
70
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gthx-20220630.htm   iXBRL 10-Q 1118584
2 EX-10.1 gthx-20220630xex101.htm EX-10.1 377217
3 EX-31.1 gthx-20220630xex311.htm EX-31.1 10615
4 EX-31.2 gthx-20220630xex312.htm EX-31.2 10592
5 EX-32.1 gthx-20220630xex321.htm EX-32.1 5802
6 EX-32.2 gthx-20220630xex322.htm EX-32.2 5452
12 gthx-20220630_g1.jpg GRAPHIC 8623
  Complete submission text file 0001628280-22-020626.txt   5963347

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gthx-20220630.xsd EX-101.SCH 45717
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gthx-20220630_cal.xml EX-101.CAL 43594
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gthx-20220630_def.xml EX-101.DEF 183293
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gthx-20220630_lab.xml EX-101.LAB 533444
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gthx-20220630_pre.xml EX-101.PRE 326806
64 EXTRACTED XBRL INSTANCE DOCUMENT gthx-20220630_htm.xml XML 816138
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 221132946
SIC: 2834 Pharmaceutical Preparations